Industry Research Reports

Home > Reports > Medical Devices & Consumables > Peripheral Arterial Disease Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Peripheral Arterial Disease Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 99 Pages

Report ld: 3499578

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Peripheral Arterial Disease Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Peripheral Arterial Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Peripheral Arterial Disease Diagnostics by region & country, by Type, and by Application.

The Peripheral Arterial Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Arterial Disease Diagnostics.

MARKET SEGMENTATION

By Company

Viasonix
Koven Technology
Natus Medical
Huntleigh
Hokanson
CooperSurgical
Perimed
Atys Medical
Newman Medical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Ankle-Brachial Index (ABI)
Ultrasonography
Angiography
Other

Segment by Application

Hospital
Clinic
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Peripheral Arterial Disease Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Peripheral Arterial Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Peripheral Arterial Disease Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Peripheral Arterial Disease Diagnostics Product Introduction

1.2 Global Peripheral Arterial Disease Diagnostics Market Size Forecast (2020-2031)

1.3 Peripheral Arterial Disease Diagnostics Market Trends & Drivers

1.3.1 Peripheral Arterial Disease Diagnostics Industry Trends

1.3.2 Peripheral Arterial Disease Diagnostics Market Drivers & Opportunity

1.3.3 Peripheral Arterial Disease Diagnostics Market Challenges

1.3.4 Peripheral Arterial Disease Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Peripheral Arterial Disease Diagnostics Players Revenue Ranking (2024)

2.2 Global Peripheral Arterial Disease Diagnostics Revenue by Company (2020-2025)

2.3 Key Companies Peripheral Arterial Disease Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Peripheral Arterial Disease Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Peripheral Arterial Disease Diagnostics

2.6 Peripheral Arterial Disease Diagnostics Market Competitive Analysis

2.6.1 Peripheral Arterial Disease Diagnostics Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Peripheral Arterial Disease Diagnostics Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease Diagnostics as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Ankle-Brachial Index (ABI)

3.1.2 Ultrasonography

3.1.3 Angiography

3.1.4 Other

3.2 Global Peripheral Arterial Disease Diagnostics Sales Value by Type

3.2.1 Global Peripheral Arterial Disease Diagnostics Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Peripheral Arterial Disease Diagnostics Sales Value, by Type (2020-2031)

3.2.3 Global Peripheral Arterial Disease Diagnostics Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Peripheral Arterial Disease Diagnostics Sales Value by Application

4.2.1 Global Peripheral Arterial Disease Diagnostics Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Peripheral Arterial Disease Diagnostics Sales Value, by Application (2020-2031)

4.2.3 Global Peripheral Arterial Disease Diagnostics Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Peripheral Arterial Disease Diagnostics Sales Value by Region

5.1.1 Global Peripheral Arterial Disease Diagnostics Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2020-2025)

5.1.3 Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2026-2031)

5.1.4 Global Peripheral Arterial Disease Diagnostics Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

5.2.2 North America Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

5.3.2 Europe Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

5.4.2 Asia Pacific Peripheral Arterial Disease Diagnostics Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

5.5.2 South America Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

5.6.2 Middle East & Africa Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.3 United States

6.3.1 United States Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.3.2 United States Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.4.2 Europe Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.5.2 China Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.5.3 China Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.6.2 Japan Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.7.2 South Korea Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.8.2 Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Peripheral Arterial Disease Diagnostics Sales Value, 2020-2031

6.9.2 India Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

6.9.3 India Peripheral Arterial Disease Diagnostics Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Viasonix

7.1.1 Viasonix Profile

7.1.2 Viasonix Main Business

7.1.3 Viasonix Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.1.4 Viasonix Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.1.5 Viasonix Recent Developments

7.2 Koven Technology

7.2.1 Koven Technology Profile

7.2.2 Koven Technology Main Business

7.2.3 Koven Technology Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.2.4 Koven Technology Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.2.5 Koven Technology Recent Developments

7.3 Natus Medical

7.3.1 Natus Medical Profile

7.3.2 Natus Medical Main Business

7.3.3 Natus Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.3.4 Natus Medical Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.3.5 Natus Medical Recent Developments

7.4 Huntleigh

7.4.1 Huntleigh Profile

7.4.2 Huntleigh Main Business

7.4.3 Huntleigh Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.4.4 Huntleigh Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.4.5 Huntleigh Recent Developments

7.5 Hokanson

7.5.1 Hokanson Profile

7.5.2 Hokanson Main Business

7.5.3 Hokanson Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.5.4 Hokanson Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.5.5 Hokanson Recent Developments

7.6 CooperSurgical

7.6.1 CooperSurgical Profile

7.6.2 CooperSurgical Main Business

7.6.3 CooperSurgical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.6.4 CooperSurgical Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.6.5 CooperSurgical Recent Developments

7.7 Perimed

7.7.1 Perimed Profile

7.7.2 Perimed Main Business

7.7.3 Perimed Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.7.4 Perimed Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.7.5 Perimed Recent Developments

7.8 Atys Medical

7.8.1 Atys Medical Profile

7.8.2 Atys Medical Main Business

7.8.3 Atys Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.8.4 Atys Medical Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.8.5 Atys Medical Recent Developments

7.9 Newman Medical

7.9.1 Newman Medical Profile

7.9.2 Newman Medical Main Business

7.9.3 Newman Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

7.9.4 Newman Medical Peripheral Arterial Disease Diagnostics Revenue (US$ Million) & (2020-2025)

7.9.5 Newman Medical Recent Developments

8 Industry Chain Analysis

8.1 Peripheral Arterial Disease Diagnostics Industrial Chain

8.2 Peripheral Arterial Disease Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Peripheral Arterial Disease Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Peripheral Arterial Disease Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Peripheral Arterial Disease Diagnostics Market Trends

Table 2. Peripheral Arterial Disease Diagnostics Market Drivers & Opportunity

Table 3. Peripheral Arterial Disease Diagnostics Market Challenges

Table 4. Peripheral Arterial Disease Diagnostics Market Restraints

Table 5. Global Peripheral Arterial Disease Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Peripheral Arterial Disease Diagnostics Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Peripheral Arterial Disease Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Peripheral Arterial Disease Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Peripheral Arterial Disease Diagnostics

Table 10. Global Peripheral Arterial Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease Diagnostics as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Peripheral Arterial Disease Diagnostics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Peripheral Arterial Disease Diagnostics Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Peripheral Arterial Disease Diagnostics Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Peripheral Arterial Disease Diagnostics Sales Market Share in Value by Type (2020-2025)

Table 17. Global Peripheral Arterial Disease Diagnostics Sales Market Share in Value by Type (2026-2031)

Table 18. Global Peripheral Arterial Disease Diagnostics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Peripheral Arterial Disease Diagnostics Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Peripheral Arterial Disease Diagnostics Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Peripheral Arterial Disease Diagnostics Sales Market Share in Value by Application (2020-2025)

Table 22. Global Peripheral Arterial Disease Diagnostics Sales Market Share in Value by Application (2026-2031)

Table 23. Global Peripheral Arterial Disease Diagnostics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2020-2025) & (%)

Table 27. Global Peripheral Arterial Disease Diagnostics Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value, (2026-2031) & (US$ Million)

Table 31. Viasonix Basic Information List

Table 32. Viasonix Description and Business Overview

Table 33. Viasonix Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Viasonix (2020-2025)

Table 35. Viasonix Recent Developments

Table 36. Koven Technology Basic Information List

Table 37. Koven Technology Description and Business Overview

Table 38. Koven Technology Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Koven Technology (2020-2025)

Table 40. Koven Technology Recent Developments

Table 41. Natus Medical Basic Information List

Table 42. Natus Medical Description and Business Overview

Table 43. Natus Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Natus Medical (2020-2025)

Table 45. Natus Medical Recent Developments

Table 46. Huntleigh Basic Information List

Table 47. Huntleigh Description and Business Overview

Table 48. Huntleigh Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Huntleigh (2020-2025)

Table 50. Huntleigh Recent Developments

Table 51. Hokanson Basic Information List

Table 52. Hokanson Description and Business Overview

Table 53. Hokanson Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Hokanson (2020-2025)

Table 55. Hokanson Recent Developments

Table 56. CooperSurgical Basic Information List

Table 57. CooperSurgical Description and Business Overview

Table 58. CooperSurgical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of CooperSurgical (2020-2025)

Table 60. CooperSurgical Recent Developments

Table 61. Perimed Basic Information List

Table 62. Perimed Description and Business Overview

Table 63. Perimed Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Perimed (2020-2025)

Table 65. Perimed Recent Developments

Table 66. Atys Medical Basic Information List

Table 67. Atys Medical Description and Business Overview

Table 68. Atys Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Atys Medical (2020-2025)

Table 70. Atys Medical Recent Developments

Table 71. Newman Medical Basic Information List

Table 72. Newman Medical Description and Business Overview

Table 73. Newman Medical Peripheral Arterial Disease Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Peripheral Arterial Disease Diagnostics Business of Newman Medical (2020-2025)

Table 75. Newman Medical Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Peripheral Arterial Disease Diagnostics Downstream Customers

Table 79. Peripheral Arterial Disease Diagnostics Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Peripheral Arterial Disease Diagnostics Product Picture

Figure 2. Global Peripheral Arterial Disease Diagnostics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Peripheral Arterial Disease Diagnostics Sales Value (2020-2031) & (US$ Million)

Figure 4. Peripheral Arterial Disease Diagnostics Report Years Considered

Figure 5. Global Peripheral Arterial Disease Diagnostics Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Peripheral Arterial Disease Diagnostics Revenue in 2024

Figure 7. Peripheral Arterial Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Ankle-Brachial Index (ABI) Picture

Figure 9. Ultrasonography Picture

Figure 10. Angiography Picture

Figure 11. Other Picture

Figure 12. Global Peripheral Arterial Disease Diagnostics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 13. Global Peripheral Arterial Disease Diagnostics Sales Value Market Share by Type, 2024 & 2031

Figure 14. Product Picture of Hospital

Figure 15. Product Picture of Clinic

Figure 16. Product Picture of Other

Figure 17. Global Peripheral Arterial Disease Diagnostics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global Peripheral Arterial Disease Diagnostics Sales Value Market Share by Application, 2024 & 2031

Figure 19. North America Peripheral Arterial Disease Diagnostics Sales Value (2020-2031) & (US$ Million)

Figure 20. North America Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

Figure 21. Europe Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 22. Europe Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

Figure 23. Asia Pacific Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 24. Asia Pacific Peripheral Arterial Disease Diagnostics Sales Value by Region (%), 2024 VS 2031

Figure 25. South America Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 26. South America Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

Figure 27. Middle East & Africa Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 28. Middle East & Africa Peripheral Arterial Disease Diagnostics Sales Value by Country (%), 2024 VS 2031

Figure 29. Key Countries/Regions Peripheral Arterial Disease Diagnostics Sales Value (%), (2020-2031)

Figure 30. United States Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 31. United States Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 32. United States Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 33. Europe Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 35. Europe Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 36. China Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 37. China Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 38. China Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 39. Japan Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 40. Japan Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 41. Japan Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 42. South Korea Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 43. South Korea Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 44. South Korea Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 45. Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 47. Southeast Asia Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 48. India Peripheral Arterial Disease Diagnostics Sales Value, (2020-2031) & (US$ Million)

Figure 49. India Peripheral Arterial Disease Diagnostics Sales Value by Type (%), 2024 VS 2031

Figure 50. India Peripheral Arterial Disease Diagnostics Sales Value by Application (%), 2024 VS 2031

Figure 51. Peripheral Arterial Disease Diagnostics Industrial Chain

Figure 52. Peripheral Arterial Disease Diagnostics Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Peripheral Arterial Disease Diagnostics market? zhanKai

The top companies in the global Peripheral Arterial Disease Diagnostics market are Viasonix、Koven Technology、Natus Medical.

Related Reports

Peripheral Arterial Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peripheral Arterial Disease Diagnostics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 102
USD 3950.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2026
The global Peripheral Arterial Disease Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 109
USD 2900.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peripheral Arterial Disease Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peripheral Arterial Disease Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 129
USD 4900.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2025
The global market for Peripheral Arterial Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 72
USD 2900.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Market Insights, Forecast to 2030
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
Published Date: 2024-04-28
Pages: 91
USD 4900.00
(Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2024
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
Published Date: 2024-01-18
Pages: 77
USD 2900.00
(Single User License)

Peripheral Arterial Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peripheral Arterial Disease Diagnostics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 102
USD 3950.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2026
The global Peripheral Arterial Disease Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 109
USD 2900.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peripheral Arterial Disease Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peripheral Arterial Disease Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 129
USD 4900.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2025
The global market for Peripheral Arterial Disease Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 72
USD 2900.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Market Insights, Forecast to 2030
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
Published: 2024-04-28
Pages: 91
USD 4900.00 (Single User License)
Global Peripheral Arterial Disease Diagnostics Market Research Report 2024
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
Published: 2024-01-18
Pages: 77
USD 2900.00 (Single User License)